ACAMPA, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 9.343
EU - Europa 8.398
AS - Asia 4.843
SA - Sud America 838
AF - Africa 286
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 23.741
Nazione #
US - Stati Uniti d'America 9.173
RU - Federazione Russa 1.789
CN - Cina 1.612
SG - Singapore 1.534
GB - Regno Unito 1.421
IT - Italia 1.233
IE - Irlanda 1.043
DE - Germania 868
BR - Brasile 697
SE - Svezia 593
VN - Vietnam 468
FR - Francia 429
HK - Hong Kong 408
UA - Ucraina 376
FI - Finlandia 257
KR - Corea 248
IN - India 165
ZA - Sudafrica 131
CA - Canada 80
NL - Olanda 67
ES - Italia 63
TR - Turchia 59
BD - Bangladesh 54
MX - Messico 52
CI - Costa d'Avorio 48
AR - Argentina 47
IQ - Iraq 45
JP - Giappone 43
NG - Nigeria 42
PL - Polonia 40
AT - Austria 37
BE - Belgio 31
CZ - Repubblica Ceca 30
PK - Pakistan 26
EC - Ecuador 24
GR - Grecia 24
AU - Australia 22
IR - Iran 22
ID - Indonesia 21
CH - Svizzera 20
KE - Kenya 17
VE - Venezuela 15
SA - Arabia Saudita 14
CL - Cile 12
CO - Colombia 12
IL - Israele 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
LT - Lituania 11
PH - Filippine 11
JM - Giamaica 9
MA - Marocco 9
NP - Nepal 9
PY - Paraguay 9
TN - Tunisia 9
CR - Costa Rica 8
MY - Malesia 8
AZ - Azerbaigian 7
DZ - Algeria 7
EU - Europa 7
KG - Kirghizistan 7
PE - Perù 7
RO - Romania 7
BG - Bulgaria 6
BO - Bolivia 6
JO - Giordania 6
LV - Lettonia 6
OM - Oman 6
SI - Slovenia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
EE - Estonia 5
HR - Croazia 5
TH - Thailandia 5
CY - Cipro 4
HU - Ungheria 4
PA - Panama 4
RS - Serbia 4
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
HN - Honduras 3
MD - Moldavia 3
MU - Mauritius 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MM - Myanmar 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
Totale 23.714
Città #
Dallas 1.306
Southend 1.165
Dublin 1.007
Singapore 892
Fairfield 800
Ashburn 748
Moscow 496
San Jose 482
Chandler 478
Santa Clara 477
Beijing 395
Hong Kong 395
Hefei 348
Woodbridge 335
Siena 298
Wilmington 296
Seattle 290
Houston 289
Jacksonville 288
Cambridge 275
Seoul 243
Ann Arbor 234
Princeton 178
Menlo Park 173
New York 168
Los Angeles 165
Milan 162
Helsinki 142
The Dalles 140
Lauterbourg 127
Ho Chi Minh City 119
Johannesburg 117
Munich 112
Nanjing 109
Council Bluffs 104
Hanoi 104
Florence 101
Dong Ket 90
Boardman 87
Dearborn 83
Vimercate 78
São Paulo 70
Buffalo 65
San Diego 63
Shanghai 55
Orem 52
Bengaluru 50
Abidjan 48
London 47
Nanchang 46
Rome 46
Chicago 43
Frankfurt am Main 42
San Mateo 42
Abuja 37
Redondo Beach 35
Tokyo 35
Turku 35
Málaga 34
Warsaw 33
Columbus 32
Lappeenranta 31
Toronto 31
Mestre 30
San Francisco 30
Pisa 29
Poggiomarino 29
Brooklyn 28
Brussels 28
Changsha 27
Shenyang 26
Montreal 25
Nuremberg 25
Denver 23
Guangzhou 23
Paris 23
Amsterdam 22
Da Nang 22
Jiaxing 22
Manchester 22
Tianjin 22
Belo Horizonte 21
Brno 20
Mexico City 20
Rio de Janeiro 20
Washington 20
Chennai 18
Jinan 18
Lancaster 18
Livorno 17
Vienna 17
Boston 16
Brasília 16
Kunming 16
Lograto 16
Stockholm 16
Zurich 16
Istanbul 15
Poplar 15
Prato 15
Totale 15.654
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 419
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 364
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 355
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 332
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 321
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 310
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 309
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting 303
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 298
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 295
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 282
Systemic thrombolysis for stroke in pregnancy 280
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 279
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 276
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 272
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 270
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 264
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome 259
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 259
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 259
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 257
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 256
Delineation of the phenotype associated with 7q36.1q36.2 deletion: long QT syndrome, renal hypoplasia and mental retardation 256
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 251
Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation. 249
Torsades de Pointes in patients with polymyalgia rheumatica 247
Cardiac dysautonomia and arterial distensibility in essential hypertensives 247
Time Course of Corticospinal Excitability and Autonomic Function Interplay during and Following Monopolar tDCS 244
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 243
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 241
Double ophthalmic arteries arising from the internal carotid artery. A case report of a hidden second ophthalmic artery 236
Aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins: response to letter 232
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 231
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 230
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 230
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 230
Neuroimaging and definition of transient ischemic attack 229
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 225
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 220
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 219
Connective tissue diseases and cardiac rhythm disorders: an overview 217
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 216
Microvascular abnormalities in Rett Syndrome 216
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 214
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 212
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 212
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 210
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 210
Stroke warning syndrome: 18 new cases 210
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 207
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 202
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 197
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 196
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 195
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 195
Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation 192
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 191
Electromagnetic fields produced by incubators influence heart rate variability in newborns 186
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 183
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 183
Sympathetic overactivity and plasma leptin levels in Rett syndrome 181
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 181
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 180
Pharmacogenetics of statins therapy 178
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 176
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 175
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 173
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 165
Letter regarding “Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series” 164
Sudden death and cardiac arrhythmias in Rett syndrome 163
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome 162
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 158
Homocysteine and P wave dispersion in patients with heart transplantation 157
Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? 155
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 155
Long-Term Risk of Arterial Thrombosis after Intracerebral Hemorrhage: MUCH-Italy 154
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients 153
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 151
Editorial: Insights in general cardiovascular medicine: 2022 149
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 144
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 143
Autonomic nervous system alterations in Rett syndrome 143
null 141
Single-center experience using the 3MAX or 4MAX reperfusion catheter for the treatment of acute ischemic stroke with distal arterial occlusions in patients not eligible for intravenous fibrinolysis 141
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 141
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 140
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: the MUCH Italy 140
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 139
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 138
The Impact of Sex and Arterial Stiffness Interactions on the Outcome after an Acute Ischemic Stroke: A Retrospective Cohort Study 137
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 137
Cardiac disease and Rett syndrome 136
Editorial: New challenges and future perspectives in autonomic neuroscience 133
Prevalence of Fabry disease and GLA variants in young patients with acute stroke: the challenge to widen the screening. The Fabry-Stroke Italian Registry 133
Editorial: Year in review: discussions in general cardiovascular medicine 132
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 132
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 129
Markers of atrial cardiopathy in severe embolic strokes of undetermined source 128
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 125
null 124
Totale 20.809
Categoria #
all - tutte 77.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 0 0 0 0 0 154 152
2021/20221.561 114 157 54 130 78 27 56 154 123 128 226 314
2022/20231.837 114 218 247 233 148 339 72 130 150 60 85 41
2023/20242.013 62 27 158 111 87 499 558 47 34 51 118 261
2024/20253.941 105 185 351 319 422 225 178 223 362 181 399 991
2025/20268.676 713 1.308 988 1.069 1.660 359 1.120 311 333 545 270 0
Totale 24.167